TriSalus Life Sciences, Inc. financial data

Symbol
TLSI, TLSIW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
6272 West 91 St Avenue, Westminster, CO
State of incorporation
DE
Fiscal year end
December 31
Former names
MedTech Acquisition Corp (to 8/10/2023), MedTech Acquisition Corporation (to 10/29/2020)
Latest financial report
10-K - Q4 2024 - Apr 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 184 % +26.7%
Quick Ratio 31 %
Debt-to-equity -192 % -628%
Return On Equity 112 % +88.9%
Return On Assets -118 % +54.8%
Operating Margin -123 % +58.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.3M shares +20.6%
Common Stock, Shares, Outstanding 31.3M shares +18.4%
Entity Public Float 82.4M USD +608%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 25.3M shares +170%
Weighted Average Number of Shares Outstanding, Diluted 25.3M shares +170%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 29.4M USD +59%
Research and Development Expense 17.7M USD -40.7%
Selling and Marketing Expense 25.8M USD +51.7%
General and Administrative Expense 18M USD -23.6%
Operating Income (Loss) -36.2M USD +33.6%
Nonoperating Income (Expense) 3.55M USD -72.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -30M USD +49.4%
Income Tax Expense (Benefit) 6K USD -33.3%
Net Income (Loss) Attributable to Parent -30M USD +49.4%
Earnings Per Share, Basic -1.31 USD/shares +80.7%
Earnings Per Share, Diluted -1.31 USD/shares +80.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.53M USD -27.6%
Accounts Receivable, after Allowance for Credit Loss, Current 5.09M USD +43.1%
Inventory, Net 4.05M USD +59.1%
Assets, Current 20.7M USD -0.93%
Property, Plant and Equipment, Net 1.82M USD -4.16%
Operating Lease, Right-of-Use Asset 1.21M USD +2.63%
Other Assets, Noncurrent 423K USD -9.23%
Assets 24M USD -2.55%
Accrued Liabilities, Current 7.36M USD -30.3%
Liabilities, Current 10.2M USD -30.4%
Operating Lease, Liability, Noncurrent 1.31M USD +13.4%
Liabilities 49.9M USD -3.48%
Retained Earnings (Accumulated Deficit) -280M USD -12%
Stockholders' Equity Attributable to Parent -25.9M USD +4.33%
Liabilities and Equity 24M USD -2.55%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.9M USD -3.47%
Net Cash Provided by (Used in) Financing Activities 3.13M USD -60.6%
Net Cash Provided by (Used in) Investing Activities -66K USD +10.8%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 31.3M shares +18.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.81M USD -195%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.88M USD -26.8%
Deferred Tax Assets, Valuation Allowance 61.3M USD +19.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 61.7M USD +19.2%
Operating Lease, Liability 1.45M USD +1.12%
Payments to Acquire Property, Plant, and Equipment 66K USD +843%
Lessee, Operating Lease, Liability, to be Paid 2.24M USD +17.9%
Operating Lease, Liability, Current 136K USD -50.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 298K USD +45.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 322K USD -15.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.14 pure +74.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 793K USD +68.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 371K USD +74.2%
Deferred Tax Assets, Operating Loss Carryforwards 44.3M USD +18.8%
Preferred Stock, Shares Issued 3.99M shares -0.75%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 300K USD +37%
Additional Paid in Capital 254M USD +14%
Preferred Stock, Shares Outstanding 3.99M shares -0.75%
Amortization of Intangible Assets 13K USD -40.9%
Interest Expense 887K USD +21825%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%